期刊文献+

单克隆抗体的制备及其应用研究进展 被引量:1

原文传递
导出
摘要 抗体是机体免疫系统的重要效应分子,从第一代多克隆抗体(polyclonal antibody,PcAb)到第二代单克隆抗体的成功制备,人们投入了大量的临床应用研究。
出处 《浙江省医学科学院学报》 2009年第3期-,共4页
  • 相关文献

同被引文献9

  • 1王业荣,童德文,李立,刘文明,王业炳.人源化抗体制备及其应用研究进展[J].生物技术通讯,2007,18(4):683-687. 被引量:7
  • 2CHEUNG KC,WONG LG,YEUNG YM. Treatment of CD33 positive refractory acute lymphoblastic leukemia with My- lotarg[J]. Leuk Lymphoma, 2008,49 (3):596-597.
  • 3KASHIF M,QURESHI A, ADIL SN, et al. Successful use of rituximab in Evans syndrome and refractory immune thrombocytopenic purpura[J]. J Pak Med Assoc, 2010, 60 (1):64-65.
  • 4YAMASHITA M, KATAKURA Y, SHIRAHATA S, et al. Recent advances in the generation of human monoclonal antibody[J].Cytotechnology,2007,55:55-60.
  • 5YAMAZAKI S, SUZUKI N, SAITO T, et al. A rapid and ef- ficient strategy to generate allele-specific anti-HLA monoclonal antibodies [J]. J Immunol Methods, 2009, 343 (1):56-60.
  • 6MERRILL Jr, NEUWELT CM, WALLACE DJ, et al. Ett~- cacy and safety of rituximab in moderately-to-severely active systemic lupus erythematosus: the randomized, double-blind, phase II/III systemic lupus erythematosus e- valuation of rituximab trim [J]. Arthritis Rheum,2010, 62(1): 222-233.
  • 7BISSONNETFE R,LANGLEY RG, PAPP K, et al. Human- ized anti-CD2monoclonal antibody treatment of plaque psoriasis: efficacy and pharmacodynamic results of two randomized, double-blind, placebo controlled studies of intravenous and subcutaneous siplizum-ab [J]. Arch Dermatol Res, 2009, 301(6):429-442.
  • 8METZ M,BERGMANN P, ZUBERBIER T, et al. Successful treatment of cholinergic urticaria with anti-immunoglobulin E therapy[J].Allergy,2008,63(2):247-249.
  • 9赵小玲,陈伟强,李静梅,张素娟,田露芳,王亮,弓景波,杨志华.应用核糖体展示技术筛选制备抗TNF-α人源抗体的研究[J].细胞与分子免疫学杂志,2009,25(2):145-149. 被引量:8

引证文献1

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部